Banker Haris Santana argues that apps have made banking quicker, but customer trust is still won by people who explain, help and act when something goes wrong.
Mobile apps have taken much of the waiting out of banking.
FI Works founder Keith Henkel says community banks and credit unions have the data, but lack a way to turn a warning sign into a call to the right person.
FI Works, which builds a relationship intelligence and engagement platform for community banks and credit unions, has launched Signals, a feature that uses machine learning to spot households likely to add a product, take up digital services or leave the
Netcall's Pol Brouckaert argues that as AI makes fake documents easier to produce, checks on whether evidence can be trusted must sit inside workflows.
Businesses have spent years automating the processing of claims, applications and supporting documents.
The Uruguayan cross-border payments platform joins a $12.2 trillion benchmarked index universe, broadening institutional exposure to emerging-market financial rails.
The Uruguayan cross-border payments platform joins a $12.2 trillion benchmarked index universe, broadening institutional exposure to emerging-market financial rails.
MoIAT and NYUAD formalise a commercialisation pipeline targeting robotics, additive manufacturing and smart materials under the UAE's AED 300bn industrial strategy.
MoIAT and NYUAD formalise a commercialisation pipeline targeting robotics, additive manufacturing and smart materials under the UAE's AED 300bn industrial strategy.
A Series A backed by European and banking-linked VCs positions Wultra to ride the post-quantum cryptography migration now reshaping financial identity.
A Series A backed by European and banking-linked VCs positions Wultra to ride the post-quantum cryptography migration now reshaping financial identity.
Nasdaq-listed Solmate says it plans to resell UAE-sourced GPU capacity for AI training and inference, with payment options including Solana stablecoins.
The EMA's advisory committee recommended secukinumab for patients aged 12 and over with moderate to severe hidradenitis suppurativa, with an EC decision expected within